EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ready-to-Use Versus Traditional IV Piggyback Preparation: A Combined Process-Error, Workforce-Time-Waste, and Cost-Effectiveness Analysis

John B. Hertig, Les Louden, William P. Raley, Michael Stepanovic, Daniel Degnan, Prachi Arora

Pharmacy · 11.11.2026 · 14 (8) · 169

DOI: 10.3390/pharmacy14080169 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacy, online erschienen am 11.11.2026. Verfasst von John B. Hertig und 5 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Baxter Healthcare Corporation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Manual IV medication preparation requires multiple discrete steps, each a potential point of process deviation, while manufacturer-prepared ready-to-use (MP-RTU) products avoid many manual compounding steps. The peer-reviewed literature describing and quantifying real-world process-error and workforce-time-waste (WTW) differences between traditional IV piggyback (IVPB) and MP-RTU products remains limited.

Methods

Two complementary studies were conducted. The Alpha study was a prospective, direct-observation study of 100 micafungin (47 steps) and 100 norepinephrine (15 steps) preparations at a 541-bed hospital. The Bravo study was a retrospective operational analysis of utilization, request burden, time to administration, and preparation cost for four medications at a 615-bed hospital. The results informed a decision-analytic cost-effectiveness model (1-year horizon, health-system perspective) comparing MP-RTU with IVPB, with sensitivity analyses.

Results

Micafungin preparations contained 208 process errors (4.4%; 67% with ≥1 error), concentrated in drug withdrawal, syringe assembly, and material collection; norepinephrine preparations contained 100 errors (6.7%; 70% with ≥1 error), concentrated in hood preparation/compounding. Pharmacy-prepared insulin and vasopressin showed higher request burden and roughly 2 h longer time to administration than MP-RTU equivalents. MP-RTU dominated IVPB in the model, with a base-case incremental cost-effectiveness ratio of −$4954.15 per additional error avoided, robust across sensitivity analyses.

Conclusions

Manual IV preparation introduced process error and operational burden that was either reduced or absent with MP-RTU; this was also less costly and more effective in the model. The findings support considering process-error opportunity and operational burden, not acquisition cost alone, when evaluating IV medication-preparation strategies.

Förderung

  • Baxter Healthcare Corporation

Zitieren

APA

Hertig, J. B., Louden, L., Raley, W. P., Stepanovic, M., Degnan, D., & Arora, P. (2026). Ready-to-Use Versus Traditional IV Piggyback Preparation: A Combined Process-Error, Workforce-Time-Waste, and Cost-Effectiveness Analysis. Pharmacy, 14(8), 169. https://doi.org/10.3390/pharmacy14080169

Vancouver

Hertig JB, Louden L, Raley WP, Stepanovic M, Degnan D, Arora P. Ready-to-Use Versus Traditional IV Piggyback Preparation: A Combined Process-Error, Workforce-Time-Waste, and Cost-Effectiveness Analysis. Pharmacy. 2026;14(8):169. doi:10.3390/pharmacy14080169

BibTeX
@article{Hertig2026,
  author = {Hertig, John B. and Louden, Les and Raley, William P. and Stepanovic, Michael and Degnan, Daniel and Arora, Prachi},
  title = {Ready-to-Use Versus Traditional IV Piggyback Preparation: A Combined Process-Error, Workforce-Time-Waste, and Cost-Effectiveness Analysis},
  journal = {Pharmacy},
  year = {2026},
  volume = {14},
  number = {8},
  pages = {169},
  doi = {10.3390/pharmacy14080169}
}
Kostenlos starten →